Lipocine (LPCN) vs Quantum Biopharma (QNTM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Lipocine (LPCN) has outperformed Quantum Biopharma (QNTM) over the past year, losing 38.9% versus a loss of 80.3%. Over five years, LPCN leads with a -90.0% price change compared with -96.7% for QNTM. Quantum Biopharma is the larger company by market cap ($20.0 million vs $15.9 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LPCN | QNTM |
|---|---|---|
| Share price | $1.93 | $3.11 |
| Market cap | $15.91M | $20.00M |
| 1-day change | -12.27% | -1.11% |
| YTD return | -75.97% | -57.40% |
| 1-year return | -38.92% | -80.28% |
| 5-year return | -89.95% | -96.65% |
| EPS (TTM) | $-1.85 | $-4.98 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.37 | $16.36 |
| 52-week low | $1.81 | $2.07 |
| Distance from 52-week high | -84.40% | -80.99% |
| Analyst consensus | none | none |
| Avg. price target upside | +159.07% | +294.53% |
| Average volume | 1.72M | 205.30K |
| Shares outstanding | 8.24M | 6.43M |
| Employees | 14 | — |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LPCN has outperformed QNTM by 41.4 percentage points over the past year.
About Lipocine
LPCN stock →Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs using its proprietary delivery technology. The company offers TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate.
Healthcare · Biotechnology · 14 employees
About Quantum Biopharma
QNTM stock →Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments.
Healthcare · Biotechnology
LPCN vs QNTM FAQ
Which is bigger, Lipocine or Quantum Biopharma?
Quantum Biopharma (QNTM) is larger, with a market capitalization of $20.00M compared with $15.91M for Lipocine (LPCN).
Which stock has performed better over the past year, LPCN or QNTM?
LPCN returned -38.92% over the past 12 months, compared with -80.28% for QNTM (price return, excluding dividends). Past performance does not predict future results.
Are Lipocine and Quantum Biopharma in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.